Press Releases | Arnold Ventures

NEW POLL: Majority of Americans Support Lower Drug Prices, Demand Congress Act

04.22.2025

Lower Federal Spending by Cutting Unnecessary Health Care Costs, Not Coverage

04.07.2025

Inclusion of Billing Transparency and Patent Reform in End-of-Year Spending Package a Win for Americans

12.17.2024

Arnold Ventures Optimistic Upon Seeing the First Round of Medicare Negotiated Drug Prices Announced

08.15.2024

Arnold Ventures Commends Senate on Unanimous Passage of the Affordable Prescriptions for Patients Act

07.11.2024

New Law Goes Into Effect to Strengthen The Maryland Prescription Drug Affordability Board

04.11.2023

California Selects Civica Rx as Its Insulin Manufacturing Partner

03.20.2023

Statement from Laura and John Arnold on Landmark Law to Lower Prescription Drug Prices

08.16.2022

Statement from Laura and John Arnold Following Senate Passage of the Inflation Reduction Act of 2022

08.07.2022

“It’s time to finish the job.”: Statement from Mark E. Miller on Historic Opportunity for Congress to Lower Prescription Drug Prices

06.30.2022

Statement from Mark E. Miller on New Insulin Legislation Offered in Senate

06.23.2022

Arnold Ventures’ Statement on the Removal of Drug Pricing from the Build Back Better Framework

10.28.2021

Arnold Ventures’ Statement on the Elijah E. Cummings Lower Drug Costs Now Act

04.22.2021